Gamida Cell Ltd (NASDAQ:GMDA)
| 0.85 Delayed Data As of Sep 22 |  -0.0596 / -6.55%Today’s Change | 0.56 Today|||52-Week Range 2.51 | -34.11% Year-to-Date |
Latest GMDA News | Press Releases
No recent news for Gamida Cell Ltd.
Today’s Trading
| Previous close | 0.91 |
| Today’s open | 0.89 |
| Day’s range | 0.84 - 0.90 |
| Volume | 62,912 |
| Average volume (3 months) | 1,720,117 |
| Market cap | $148.2M |
Data as of 3:59pm ET, 09/22/2023
Growth & Valuation
| Earnings growth (last year) | +17.95% |
| Earnings growth (this year) | +37.10% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CTXRCitius Pharmaceutica... | +0.01 | +1.36% |
| ---- | ||
| ---- | ||
| GRTSGritstone bio Inc | 0.00 | 0.00% |
Data as of 3:59pm ET, 09/22/2023
Financials
| Next reporting date | November 13, 2023 |
| EPS forecast (this quarter) | -$0.18 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$79.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
